Skip to content
AfricureAnalytics
  • Home
  • About
  • Solutions
  • Demos
  • Partnerships
  • Platform
  • Contact
Contact us
Navigation
  • Home
  • About
  • Solutions
  • Demos
  • Partnerships
  • Platform
  • Contact
Contact us
AfricureAnalytics

Health analytics tools for institutions, researchers, and programmes across Africa.

General enquiries
hello@africureanalytics.com
Phone
+2349023885989
Address
Lagos, Nigeria

Company

  • About
  • Team
  • Impact
  • Partnerships
  • Articles

Solutions

  • All solutions
  • Live demos
  • Diabetes risk analytics
  • Image pattern analytics
  • Population analytics

Trust

  • Research and methodology
  • Evidence and governance
  • Security
  • Privacy policy
  • Scope and intended use

Africure Analytics builds analytics, reporting, and monitoring tools. We do not provide clinical services or medical advice.

PrivacyTermsScope and intended use

Copyright 2026 Africure Analytics. All rights reserved.

Interactive demo

Breast Cancer Recurrence Analytics Demo

See how surgery, age, tumour size, and chemotherapy inputs produce a recurrence risk estimate for reporting and research review.

Interactive demoAnalytics workbenchSample inputs
Sign in to platformView solution details
Live demo

Breast Cancer Recurrence Analytics Demo

See how surgery, age, tumour size, and chemotherapy inputs produce a recurrence risk estimate for reporting and research review.

Reference: Khan, O., Ajadi, J. O., Almsned, F., Almohanna, H., Alrasheed, A., Sanusi, R. A., & Adegoke, N. A. (2025). Prognostic model for predicting recurrence in breast cancer patients in Saudi Arabia. Scientific Reports, 15(1), 18388.

Analytical output
12.84%
Minimal recurrence risk band

Estimated risk from weighted input factors

Results interpretation

The probability of experiencing breast cancer recurrence is 12.84%. In other words, 12.84 out of 100 people with the same risk factors as your patient will experience a recurrence of breast cancer.

Best used for research review, registry analysis, and recurrence-monitoring reporting alongside specialist interpretation.

Key drivers
  • Baseline inputs only. Signal is low and should be read with care.